Braidwell’s Olema Pharmaceuticals OLMA Stock Holding History

Braidwell’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-704,344	Closed	-$7.97M	–	83
2024 Q1	$7.97M	Buy	+704,344	New	+$9.09M	0.26%	63

Other funds holding OLMA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Braidwell's OLMA Position: Q2 2024 in Review

Braidwell sold out of Olema Pharmaceuticals (OLMA) in Q2 2024, closing a stake of 704,344 shares — an estimated $7.97M sold.

Braidwell first reported a position in OLMA in Q1 2024 and held it in 1 quarter. The position peaked at $7.97M in Q1 2024. 128 funds tracked by Wall St. Rank hold OLMA as of Q2 2024.

Braidwell reported no remaining Olema Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Braidwell sold 704,344 Olema Pharmaceuticals shares in Q2 2024, an estimated $7.97M.
Braidwell first reported a position in Olema Pharmaceuticals in Q1 2024 and held it in 1 quarter.
Braidwell's Olema Pharmaceuticals position peaked at $7.97M in Q1 2024.
128 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2024.

Based on Braidwell's 13F filing for Q2 2024, filed 14 Aug 2024.